Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
10
Mins
6 Feb 2024
The Evolution of Pruritus Management for People with Primary Biliary Cholangitis
PBC is a chronic, progressive, immune-mediated cholestatic liver disease that involves gradual intrahepatic bile duct destruction…
19 Jan 2024
Low Screening and Treatment for Osteoporosis in Patients with Cirrhosis
Screening for osteoporosis is considerably lower in patients with cirrhosis compared with the general population, and less than 25% of those with low bone density are treated, according to a recent study. Read more.
12 Jan 2024
Adult-Onset Progressive Familial Intrahepatic Cholestasis: Case Study
This video is a short clip extracted from the integrated symposium at the 58th Annual Meeting of the European Association for the Study of…
7
Mins
24 Nov 2023
Spontaneous Subcapsular Hepatic Haematoma: A Rare Case Report
A spontaneous subcapsular hepatic haematoma (SHH) is both a rare and potentially life-threatening condition. Although the pathogenesis of…
8 Nov 2023
Does Testosterone Replacement Improve Steatotic Liver Disease?
Male hypogonadism is associated with visceral obesity and metabolic syndrome. The present study aims to compare the effects of testosterone treatment with a placebo in treating non-alcoholic fatty liver disease in older hypogonadal males.
7 Nov 2023
Novel Scoring Tool Predicts Alcoholic Relapse Following Liver Transplant
New data suggests that the risk of alcoholic relapse in patients with alcohol-related liver disease who underwent liver transplant may be more accurately determined with the help of a new scoring system.
13 Oct 2023
Waitlist Outcomes Improved by Living Donor Liver Transplantation
Waitlist outcomes are improved by living donor liver transplantation for high-risk patients with cirrhosis, according to a recent study. This study aimed to assess the impact of access to LDLT in waitlisted patients at highest risk of dropout.
13 Oct 2023
Hypertriglyceridaemia Associated with Severity of Pancreatitis in Non-alcoholic Fatty Liver Disease
Higher triglyceride levels have been linked with incidence of moderately severe and severe acute pancreatitis in non-alcoholic fatty liver disease. The complications of this hypertriglyceridaemia included organ failure and acute peripancreatic fluid collection.
Loading posts...
« Previous
1
…
36
37
38
39
40
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View